Real-time enrollment status for this duchenne muscular dystrophy with mutations amenable to pbgene-dmd clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 10:05 PM UTC
| NCT Number | NCT07429240 |
| Recruiting Status | Recruiting |
| Condition | Duchenne Muscular Dystrophy With Mutations Amenable to PBGENE-DMD |
| Phase | PHASE1 |
| Target Enrollment | 18 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Precision BioSciences, Inc. |
| Last Updated on CT.gov | June 23, 2026 (Jun 23, 2026) |
As of August 29, 2026: Clinical trial NCT07429240 is currently recruiting participants. This phase1 study for duchenne muscular dystrophy with mutations amenable to pbgene-dmd is actively seeking new participants at 2 locations across the United States. The study is sponsored by Precision BioSciences, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07429240 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07429240 was last updated Jun 23, 2026 (June 23, 2026). HelloStudys verifies this status automatically.